Concepedia

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

Michael P. Manns, Patrick Marcellin, Fred Poordad, Evaldo Stanislau Affonso de Araújo, Yves Horsmans, Ewa Janczewska, Federico Villamil, Jane Scott, Monika Peeters, Oliver Lenz,

The Lancet · 2014 · 375 citations · 28 references

DOI

Concepts

References

28

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

, , +17

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

, , +17

An Algorithm for the Grading of Activity in Chronic Hepatitis C

Pierre Bédossa, Thierry Poynard · Hepatology · 1996 · 4K citations · Full text

, , +17

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Dongliang Ge, Jacques Fellay, Alexander Thompson et al. · Nature · 2009 · 3.5K citations · Full text

, , +13

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

Marc G. Ghany, Doris B. Strader, David L. Thomas et al. · Hepatology · 2008 · 3K citations · Full text

, , +17